Galectin Therapeutics to Present at the RedChip Small-Cap Equities Virtual Conference

Published: Aug 23, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it will present at the RedChip Small-Cap Equities Virtual Conference.

Back to news